| Abstract: | Datamonitor's Targacept Inc Company Profile is the essential source for top-level company data and information. Targacept Inc Company Profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Targacept is a biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, for the treatment of multiple diseases and disorders of the central nervous system. The company primarily operates in the US, where it is headquartered in Winston Salem, North Carolina and employs around 113 people. The company recorded revenues of $20.1 million during the fiscal year ended December 2008, an increase of 73.5% over 2007. The company's operating loss was $28.1 million during fiscal 2008, as compared to the operating loss of $31.8 million in 2007. Its net loss was $25.7 million in fiscal 2008, as compared to the net loss of $28.1 million in 2007.
Scope of the Report
- Provides all the crucial information on Targacept Inc required for business and competitor intelligence needs
-Data is supplemented with details on Targacept Inc history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Targacept Inc
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
|
| Brief Excerpt: | ...Targacept is a biophar maceutical compan y engaged in the design, disco very and de velopment of NNR Therapeutics, f or the treatment of m ultiple diseases and disorders of the centr al ner vous system. The compan y pr imarily oper ates in the US . It is headquar tered in Winston Salem, Nor th Carolina and emplo ys about 90 people .The compan y recorded re venues of $27.5 million dur ing the fiscal y ear ended December 2006, compared to the re venues of $1.2 million in 2005. The oper ating loss of the compan y w as $0.4 million dur ing fiscal y ear 2006, compared to an oper ating loss of $29.9 million in 2005. The net profit was $1.2 million in fiscal y ear 2006, compared to a net loss of $40.2 million in 2005. ...
|
